Medical Technologies

Quality Control Material for Qualitative Determination of Antibodies to Hepatitis B e Antigen in Clinical Samples Using Chemiluminescent Immunoassay on CL Series Analyzers

Quality Control Material for Qualitative Determination of Antibodies to Hepatitis B e Antigen in Clinical Samples Using Chemiluminescent Immunoassay on CL Series Analyzers

1. Negative Control Material (Anti-HBe Negative Control)

For quality control of the qualitative determination of antibodies to the hepatitis B e antigen in clinical samples using chemiluminescent immunoassay on CL series analyzers.

Vials: 3 x 2.0 mL

Contents:

  • Anti-HBe Negative Control, 2.0 mL – 3 vials
  • Value chart of the control material batch
  • Instructions for use

2. Negative Control Material (Anti-HBe Negative Control)

For quality control of the qualitative determination of antibodies to the hepatitis B e antigen in clinical samples using chemiluminescent immunoassay on CL series analyzers.

Vials: 6 x 2.0 mL

Contents:

  • Anti-HBe Negative Control, 2.0 mL – 6 vials
  • Value chart of the control material batch
  • Instructions for use

3. Positive Control Material (Anti-HBe Positive Control)

For quality control of the qualitative determination of antibodies to the hepatitis B e antigen in clinical samples using chemiluminescent immunoassay on CL series analyzers.

Vials: 3 x 2.0 mL

Contents:

  • Anti-HBe Positive Control, 2.0 mL – 3 vials
  • Value chart of the control material batch
  • Instructions for use

4. Positive Control Material (Anti-HBe Positive Control)

For quality control of the qualitative determination of antibodies to the hepatitis B e antigen in clinical samples using chemiluminescent immunoassay on CL series analyzers.

Vials: 6 x 2.0 mL

Contents:

  • Anti-HBe Positive Control, 2.0 mL – 6 vials
  • Value chart of the control material batch
  • Instructions for use

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Quality Control Material for Qualitative Determination of Antibodies to Hepatitis B e Antigen in Clinical Samples Using Chemiluminescent Immunoassay on CL Series Analyzers, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.

Copyright MAXXmarketing GmbH
JoomShopping Download & Support